Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Human papillomavirus (HPV) infection can lead to significant disease in males, including anogenital warts, intraepithelial neoplasias, and several types of oral and anogenital cancers. The quadrivalent HPV (type 6/11/16/18) L1 virus-like particle (VLP) vaccine (qHPV vaccine; Gardasil) has recently b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hillman, Richard J., Giuliano, Anna R., Palefsky, Joel M., Goldstone, Stephen, Moreira, Edson D., Vardas, Eftyhia, Aranda, Carlos, Jessen, Heiko, Ferris, Daron G., Coutlee, Francois, Marshall, J. Brooke, Vuocolo, Scott, Haupt, Richard M., Guris, Dalya, Garner, Elizabeth I. O.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2012
Soggetti:
Vaccines
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272915/
https://ncbi.nlm.nih.gov/pubmed/22155768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05208-11
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi